期刊文献+

进行性对称性红斑角化症的临床和遗传特征分析 被引量:7

Progressive symmetric erythrokeratoderma:Analyses of clinical and genetic features
在线阅读 下载PDF
导出
摘要 目的了解中国人进行性对称性红斑角化症(PSEK)的临床表现和遗传特点。方法对该科收集的1个PSEK家系和1990年以来报道相关中国人PSEK的8个PSEK家系进行系统的临床和遗传学的总结分析。结果 (1)PSEK的典型临床表现为初发于掌跖的对称性、边界清楚的角化性红斑、部分患者皮损可扩展至其他部位,但多较为局限,多幼年发病,患者身体健康不受影响;(2)呈常染色体显性遗传;(3)同一家系内或不同家系间患者的表现度可存在明显差异;(4)多不伴发其他疾病;(5)部分家系的发病情况呈不规则显性;(6)近亲结婚家系中可见PSEK患者。结论 PSEK为一种少见的、有高外显率的常染色体显性遗传性皮肤病,临床表现以对称分布的、固定的红色角化性斑块为特征,但不同患者表现度可存在明显差异,近亲结婚患病的几率可能增加。 Objective To study clinical and genetic features of progressive symmetric erythrokeratoderma(PSEK) in Chinese. Methods The clinical and genetic features of PSEK were analyzed from one PSEK pedigree collected by clinic and studied by reviewing 8PSEK families reported in China since 1990. Results(1)The clinic features included hyperkeratotic plaques with distinct border and strikingly symmetric distribution pattern on the extremities. As the age of the patients was advancing,the lesions extended to other areas of the body. The onset of the disease often started in infancy or childhood. The general health condition was not affected.(2)The pattern of inheritance was autosomal dominant.(3)There was a marked variability in disease expression not only between families but also within a family.(4)Some families showed a pattern of irregular dominance.(5) Few patients presented with other coincident dermatoses.(6)Some patients with PSEK were found in the family of consanguineous marriage. Conclusions PSEK is a rare disease in Chinese based on the published literatures and is an autosomal dominant skin disease with high penetrance. The typical PSEK is characterized by symmetrical hyperkeratotic plaques on the extremities and there is difference in phenotype among the individuals. Consanguineous marriage probably increases the risk of PSEK.
出处 《安徽医药》 CAS 2014年第8期1446-1449,共4页 Anhui Medical and Pharmaceutical Journal
基金 国家自然科学基金项目(No 81301352)
关键词 进行性对称性红斑角化症 显性遗传 PSEK dominant heredity
  • 相关文献

参考文献14

  • 1Akman A, Masse M, Mihci E, et aL Progressive symmetrical erythrokeratoderma , report of a Turkish family and evaluation for loricrin and connexin gene mutations [J] . Clin Exp Dermatol, 2008 , 33 (5) :582 -584.
  • 2Stnescu L,Georgescu CV ,Georgescu AC,et al. Erythrokeratodermia variabilis - variant with circumscribed variable erythema and peri orificial fixed Bazex Dupre erythema [J] . Rom J Morphol Em- bryol ,2007,48 (4) :443 - 447.
  • 3Guo BR, Sun LD, Cui Y, et al. Progressive symmetrical erythroker- atoderma , report of two Chinese families and evaluation for muta- tions in the loricrin, connexin 30. 3 and connexin 31 genes [J] . Clin Exp Dermatol,2013,38(8) :925 -927.
  • 4Yan HB, Zhang J, Liang W, et aL Progressive symmetric erythrokeratoderma , report of a Chinese family [J] . Indian J Dennatol Ve- nereol Leprol ,2011 ,77 (5) :597 - 600.
  • 5Hirano SA, Harvey VM. From progressive symmetric erythrokerato- derma to erythrokeratoderma variahilis progressiva[J] . J Am Acad Dermatol ,2010 ,64(5) :81 - 82.
  • 6Ishida-Yamamoto A, Mc Grath JA, Lam H, et al. The molecular pa- thology of progressive symmetric erythrokeratoderma , a frarneshift mutation in the loricrin gene and perturbations in the cornified cell envelope [Jl. Am J Hum Genet, 1997 ,61 (3) :581 -589.
  • 7Suga Y, Jamik M, Attar PS, et al. Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin disea- ses , Vohwinkel syndrome and progressive symmetric erythrokerato- dermal J J. J Cell Biol,2000, lSI (2) :401 -412.
  • 8Richard G, Brown N, Rouan F, et al. Genetic heterogeneity in erythrokeratodermia variahilis , novel mutations in the connexin gene GJB4 (Cx30. 3) and genotype-phenotype correlations [J] . J Invest Dermatol, 2003 ,120 ( 4 ) : 60 1 - 609.
  • 9Cui Y, Yang S, Gao M , et al. Identification of a novel locus for pro- gressive symmetric erythrokeratodermia to a 19, 02 - cM interval at 21ql1.2 -21q21. 2[J] . J Invest Dermatol,2006,126(9) :2136 -2139.
  • 10袁相凤,李平,崔勇,杨森.进行性对称性红斑角化症1家系报道[J].中国皮肤性病学杂志,2010,24(1):73-74. 被引量:7

二级参考文献12

  • 1张凤翔.进行性对称性红斑角化病4代7例报告.中华皮肤科杂志,1985,18(3):188-188.
  • 2Gray LC, Davis LS, Guill MA. Progressive symmetric e rythrokeratodermia[ J]. J Am Acad Dermatol, 1996(34) : 858 -85.
  • 3Ishida-Yamamoto A, McGrath JA, Lam H, et al. The molecular pathology of autosomal dominant erythrokeratoderma: a frameshift mutation ill the loricrin gene and perturbations in the cornified cell envelope [ J ]. Am J Hum Genet, 1997 (61) : 581 -589.
  • 4Cui Y, Yang S, Gao M, et al. Identification of a novel locus for progressive symmetric erythrokeratodermia to a 19.02-cM interval at 21 q11.2-21q21.2 [ J ]. J Invest Dermatol,2006, 126(9) : 2136 -2139.
  • 5张凤翔.进行性对称性红斑角化病4代7例报道[J].中华皮肤科杂志,1985,18:188-188.
  • 6汪新义 张基瑞 陈树民.进行性对称性红斑角化病一家族报告[J].中华皮肤科杂志,1995,28:337-337.
  • 7姚春华.进行性对称性红斑角化症3例报告[J].中华皮肤科杂志,1984,17:129-129.
  • 8Hirano SA,Harvey VM, From progressive symmetricerythrokeratoderma to erythrokeratoderma variabilis progressiva[J]. J Am Acad Dermatol, 2011, 64(5):e81-82.
  • 9Richard G,Brown N, Smith LE, et al. The spectrum of mutationsin erythrokeratodermias-nove丨 and de novo mutations in GJB3[J]. Hum Genet, 2002, 106(3):321-329.
  • 10Cui Y, Yang S, Gao M, et al. Identification of a novel locus forprogressive symmetric erythrokeratodermia to a 19.02-cMinterval at 21 q 11.2-21 q21.2 [J]. J Invest Dermatol, 2006,126(9):2136-2139.

共引文献15

同被引文献57

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部